Rosetta Genomics Ltd. (ROSGQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Feb 21, 2025, 3:00 PM EST
Rosetta Genomics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2011 - 2007 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '17 Jun 30, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | 2011 - 2007 |
| Net Income | -13.39 | -16.23 | -17.35 | -14.53 | -12.9 | -10.46 | Upgrade
|
| Depreciation & Amortization | 0.24 | 0.27 | 0.3 | 0.3 | 0.3 | 0.27 | Upgrade
|
| Other Amortization | 0.57 | 0.57 | 0.56 | - | - | 1.55 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -0.02 | Upgrade
|
| Stock-Based Compensation | 0.8 | 0.86 | 1.02 | 0.94 | 0.89 | 0.55 | Upgrade
|
| Other Operating Activities | -1.75 | -0.01 | 0.9 | -0.08 | -0.32 | 0.37 | Upgrade
|
| Change in Accounts Receivable | -0.15 | 0.01 | -0.01 | -0.11 | -0.14 | -0.08 | Upgrade
|
| Change in Accounts Payable | 0.41 | 0.25 | 0.06 | -0.34 | 0.15 | 0.17 | Upgrade
|
| Change in Unearned Revenue | - | - | - | -0.23 | - | - | Upgrade
|
| Change in Other Net Operating Assets | -0.78 | 2.32 | -1.77 | 0.45 | 0.78 | -1.03 | Upgrade
|
| Operating Cash Flow | -11.68 | -10.6 | -16.93 | -13.6 | -10.61 | -8.64 | Upgrade
|
| Capital Expenditures | -0.04 | -0.11 | -0.12 | -0.25 | -0.63 | -0.27 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.06 | Upgrade
|
| Cash Acquisitions | - | - | -2.12 | - | - | - | Upgrade
|
| Investment in Securities | 0 | 0.5 | 7.15 | -0.01 | -7.53 | -0.02 | Upgrade
|
| Other Investing Activities | 0.92 | 0.66 | -0.78 | - | - | 0 | Upgrade
|
| Investing Cash Flow | 0.88 | 1.05 | 4.13 | -0.26 | -8.15 | -0.23 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 1.75 | Upgrade
|
| Long-Term Debt Issued | - | 3.71 | - | - | - | - | Upgrade
|
| Total Debt Issued | 5 | 3.71 | - | - | - | 1.75 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -1.45 | Upgrade
|
| Long-Term Debt Repaid | - | -0.03 | - | - | - | -0.03 | Upgrade
|
| Total Debt Repaid | -0.06 | -0.03 | - | - | - | -1.48 | Upgrade
|
| Net Debt Issued (Repaid) | 4.94 | 3.68 | - | - | - | 0.27 | Upgrade
|
| Issuance of Common Stock | - | - | 17.32 | 5.02 | 4.74 | 38.65 | Upgrade
|
| Other Financing Activities | -0.42 | -0.42 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 4.52 | 3.26 | 17.32 | 5.02 | 4.74 | 38.93 | Upgrade
|
| Net Cash Flow | -6.29 | -6.28 | 4.52 | -8.85 | -14.02 | 30.06 | Upgrade
|
| Free Cash Flow | -11.73 | -10.7 | -17.05 | -13.85 | -11.23 | -8.91 | Upgrade
|
| Free Cash Flow Margin | -410.21% | -524.96% | -593.04% | -1043.63% | -2773.83% | -4431.34% | Upgrade
|
| Free Cash Flow Per Share | -5.61 | -5.81 | -13.56 | -14.79 | -14.05 | -24.03 | Upgrade
|
| Cash Interest Paid | - | - | - | - | - | 0.29 | Upgrade
|
| Levered Free Cash Flow | -6.04 | -2.89 | -13.14 | -7.93 | -6.85 | -5.23 | Upgrade
|
| Unlevered Free Cash Flow | -6.18 | -3.09 | -13.33 | -7.9 | -6.84 | -5.63 | Upgrade
|
| Change in Net Working Capital | 0.56 | -3.78 | 6.35 | -0.01 | -0.94 | 1.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.